MET and malignant colon neoplasm: Qiu et al. revealed that Norcantharidin (NCTD) suppressed cell proliferation and induced G2/M phase arrest via decreasing the levels of the total EGFR, the activated EGFR, the total c-MET, and the activated c-MET in colon cancer cells (HCT116 and HT29 cells) [70].